Takaoka, Japan

Hidetada Mikami


Average Co-Inventor Count = 9.6

ph-index = 3

Forward Citations = 20(Granted Patents)


Company Filing History:


Years Active: 1983-1992

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Hidetada Mikami: Innovator in Antitumor Agents

Introduction

Hidetada Mikami is a notable inventor based in Takaoka, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of antitumor agents. With a total of 3 patents, his work focuses on innovative compounds that exhibit promising therapeutic effects.

Latest Patents

Mikami's latest patents include groundbreaking inventions such as isoindole derivatives and salts thereof, which serve as antitumor agents. One of his notable inventions is a novel isoindole derivative represented by a specific general formula, which demonstrates excellent antitumor activity coupled with low toxicity. Additionally, he has developed a pharmaceutical composition that comprises an extract from the poison pouch contents of bees. This composition has shown immunostimulating activity, carcinostatic activity, and the ability to enhance the antibacterial activity of other substances.

Career Highlights

Hidetada Mikami is currently associated with Toyama Chemical Co., Ltd., where he continues to advance his research and development efforts. His work has been instrumental in creating effective pharmaceutical solutions that address critical health challenges.

Collaborations

Mikami has collaborated with esteemed colleagues such as Isamu Saikawa and Takashi Yasuda, contributing to the innovative research environment at his company.

Conclusion

Hidetada Mikami's contributions to the field of pharmaceuticals, particularly in antitumor agents, highlight his innovative spirit and dedication to improving health outcomes. His patents reflect a commitment to developing effective and safe therapeutic options.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…